Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liesbeth De Wever

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Brachytherapy|July 24, 2013
CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapyMarisol De Brabandere, Bashar Al-Qaisieh, Liesbeth De Wever, et al.
Cancers|August 23, 2020
Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical ProstatectomyGaëtan Devos, Charlien Berghen, Henri Van Eecke, et al.
Acta Oncologica (Stockholm, Sweden)|April 17, 2020
Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitorsBenoit Beuselinck, Steven Pans, Jurgen Bielen, et al.
EJNMMI Research|April 30, 2021
Parameters predicting [<sup>18</sup>F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancerNiloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, et al.
The Journal of Urology|November 14, 2019
Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node DissectionCédric Draulans, Wouter Everaerts, Sofie Isebaert, et al.
Neurourology and Urodynamics|July 5, 2022
The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional studyManuela Tutolo, Giuseppe Rosiello, Giorgio Stabile, et al.
Acta Oncologica (Stockholm, Sweden)|May 6, 2026
Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysisAaron Caeyman, Giulia Mammone, Lisa Kinget, et al.
Clinical Genitourinary Cancer|August 7, 2021
Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant TrialsEduard Roussel, Annelies Verbiest, Lisa Kinget, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2024
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumabYana Beulque, Lisa Kinget, Eduard Roussel, et al.
European Urology Focus|August 3, 2023
Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral CenterAlessio Pecoraro, Laura Elst, Eduard Roussel, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Brachytherapy|July 24, 2013
CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapyMarisol De Brabandere, Bashar Al-Qaisieh, Liesbeth De Wever, et al.
Cancers|August 23, 2020
Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical ProstatectomyGaëtan Devos, Charlien Berghen, Henri Van Eecke, et al.
Acta Oncologica (Stockholm, Sweden)|April 17, 2020
Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitorsBenoit Beuselinck, Steven Pans, Jurgen Bielen, et al.
EJNMMI Research|April 30, 2021
Parameters predicting [<sup>18</sup>F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancerNiloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, et al.
The Journal of Urology|November 14, 2019
Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node DissectionCédric Draulans, Wouter Everaerts, Sofie Isebaert, et al.
Neurourology and Urodynamics|July 5, 2022
The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional studyManuela Tutolo, Giuseppe Rosiello, Giorgio Stabile, et al.
Acta Oncologica (Stockholm, Sweden)|May 6, 2026
Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysisAaron Caeyman, Giulia Mammone, Lisa Kinget, et al.
Clinical Genitourinary Cancer|August 7, 2021
Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant TrialsEduard Roussel, Annelies Verbiest, Lisa Kinget, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2024
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumabYana Beulque, Lisa Kinget, Eduard Roussel, et al.
European Urology Focus|August 3, 2023
Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral CenterAlessio Pecoraro, Laura Elst, Eduard Roussel, et al.
Pageof 4